Yan Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yan Gao has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Mingxi Qiao
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
2 shared publications Zilin Song
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China
2 shared publicationsDawei Chen
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
1 shared publicationDawei Ding
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China
1 shared publicationJiru Shen
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
1 shared publicationRong Guo
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China
1 shared publication
Latest Publications
- 19 February 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (9) , 2963-2976
Effective inhibition of lung metastatic melanoma by pH-responsive lipopeptide/PLGA hybrid nanoparticles silencing PD-L1 with augmented suppression of the AKT/β-catenin pathway
This study proposed a novel strategy to effectively inhibit lung metastatic melanoma by suppressing the AKT/β-catenin pathway by virtue of pH-responsive C 18 -pArg 8 -pHis 10 -based lipopeptide hybrid nanoparticles.
- 19 February 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (9) , 2963-2976
Effective inhibition of lung metastatic melanoma by pH-responsive lipopeptide/PLGA hybrid nanoparticles silencing PD-L1 with augmented suppression of the AKT/β-catenin pathway
This study proposed a novel strategy to effectively inhibit lung metastatic melanoma by suppressing the AKT/β-catenin pathway by virtue of pH-responsive C 18 -pArg 8 -pHis 10 -based lipopeptide hybrid nanoparticles.
- 21 November 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 389, 114450
Inducing potent ferroptosis in cancer cells by manipulation of ferritinophagy with a ferritin-targeted ATTEC
- 21 November 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 389, 114450
Inducing potent ferroptosis in cancer cells by manipulation of ferritinophagy with a ferritin-targeted ATTEC